Reactivations in Multisystem Langerhans Cell Histiocytosis: Data of the International LCH Registry

Journal of Pediatrics

Volumn 153, Issue 5, 2008, Pages

  Minkov, Milen ^a,b   Steiner, Manuel ^b   Pötschger, Ulrike ^b   Aricò, Maurizio ^c   Braier, Jorge ^d   Donadieu, Jean ^e   Grois, Nicole ^b   Henter, Jan Inge ^f   Janka, Gritta ^g   McClain, Kenneth ^h   Weitzman, Sheila ⁱ   Windebank, Kevin ^j   Ladisch, Stephan ^k   Gadner, Helmut ^a,b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c UNIVERSITY OF FLORENCE   (Italy)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^e ARMAND TROUSSEAU HOSPITAL   (France)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h Texas Children's Hospital   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j ROYAL VICTORIA INFIRMARY   (United Kingdom)

^k CHILDREN S RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; VINBLASTINE SULFATE;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HUMAN; INFANT; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; HISTIOCYTOSIS X; INTERNATIONAL COOPERATION; NEUROGENIC DIABETES INSIPIDUS; PATHOLOGY; PATHOPHYSIOLOGY; PROBABILITY; PROSPECTIVE STUDY; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DIABETES INSIPIDUS, NEUROGENIC; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; INTERNATIONAL COOPERATION; MALE; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 55549139792     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.05.002     Document Type: Article

References (20)

1. Gadner H., Grois N., Aricò M., Broadbent V., Ceci A., Jakobson A., et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 138 (2001) 728-734
2. Minkov M., Grois N., Heitger A., Pötschger U., Westermeier T., and Gadner H. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin Pädiatr 212 (2000) 139-144
3. Haupt R., Nanduri V., Calevo M.G., Bernstrand C., Braier J.L., Broadbent V., et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42 (2004) 438-444
4. Broadbent V., and Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 327-338
5. Histiocytosis syndromes in children. Writing Group of the Histiocyte Society. Lancet 1 8526 (1987) 208-209
6. Gadner H., Heitger A., Grois N., Gatterer-Menz I., and Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 23 (1994) 72-80
7. Lahey E. Histiocytosis X: an analysis of prognostic factors. J Pediatr 87 (1975) 184-189
8. Gadner H., Grois N., Pötschger U., Minkov M., Arico M., Braier J., et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 111 (2008) 2556-2562
9. Grois N.G., Favara B.E., Mostbeck G.H., and Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12 (1998) 287-305
10. Prayer D., Grois N., Prosch H., Gadner H., and Barkovich A.J. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. Am J Neuroradiol 25 (2004) 880-891
11. Komp D.M., El Mahdi A., Starling K.A., Easley J., Vietti T.J., Berry D.H., et al. Quality of survival in histiocytosis X: a Southwest Oncology Group study. Med Pediatr Oncol 8 (1980) 35-40
12. Donadieu J., Rolon M.A., Thomas C., Brugieres L., Plantaz D., Francois Emile J., et al. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 144 (2004) 344-350
13. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group. Arch Dis Child 75 (1996) 17-24
14. Berry D.H., Gresik M.V., Humphrey G.B., Starling K., Vietti T., Boyett J., et al. Natural history of histiocytosis X: a pediatric oncology group study. Med Pediatr Oncol 14 (1986) 1-5
15. Braier J., Chantada G., Rosso D., Bernaldez P., Amaral D., Latella A., et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 16 (1999) 377-385
16. Raney Jr. R.B., and D'Angio G.J. Langerhans' cell histiocytosis (histiocytosis X): experience at the Children's Hospital of Philadelphia, 1970-1984. Med Pediatr Oncol 17 (1989) 20-28
17. Titgemeyer C., Grois N., Minkov M., Flucher-Wolfram B., Gatterer-Menz I., and Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 37 (2001) 108-114
18. Pollono D., Rey G., Latella A., Rosso D., Chantada G., and Braier J. Reactivation and risk of sequelae in Langerhans cell histiocytosis. Pediatr Blood Cancer 48 (2007) 696-699
19. Morimoto A., Kobayashi R., Maeda M., Asami K., Bessho F., and Imashuku S. Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients [letter]. Pediatr Blood Cancer 50 (2008) 931
20. Donadieu J., Piguet C., Bernard F., Barkaoui M., Ouache M., Bertrand Y., et al. A new clinical score for disease activity in Langerhans cell histiocytosis. Pediatr Blood Cancer 43 (2004) 770-776